Will genital warts recur after applying recombinant human interferon α2b gel?

Applying recombinant human interferon α2b gel may still result in the recurrence of warts. This gel is primarily used for human papillomavirus (HPV) infection and exerts antiviral effects, including inhibition of viral replication and prevention of recurrence. However, it does not completely eradicate or cure the virus. Details are as follows:

Recombinant human interferon α2b gel is a topical agent indicated for HPV infection and is clinically useful in treating gynecological conditions such as genital warts (condyloma acuminatum), cervical ectopy (ectocervical columnar epithelium), and vulvar eczema. It is generally effective for small warts; however, for larger warts or multiple lesions, interferon serves mainly as an adjunctive therapy and a preventive measure against recurrence.

In clinical practice, wart management must be individualized based on factors including wart type, patient’s medical history, and age. Not all warts require treatment—some may spontaneously resolve without intervention. Treatment options include physical modalities and topical medications. Physical therapies encompass electrocautery and liquid nitrogen cryotherapy; topical agents include recombinant human interferon α2b gel, imiquimod cream, and fluorouracil ointment. Typically, after physical ablation, interferon gel may be prescribed by a physician to reduce the risk of recurrence. Nevertheless, in patients with severe or persistent HPV infection, warts may still recur despite topical interferon use.

In daily life, avoid scratching or rubbing warts, as this may promote their spread and worsen the condition. Maintain local skin hygiene to prevent secondary infection. Engage regularly in physical exercise to strengthen overall health and enhance immune function. Topical interferon provides only supportive antiviral and inhibitory effects; if warts recur, consult a specialized hospital and follow your physician’s guidance for appropriate management.